Substanzen · Tryptamin-Derivate
5-MeO-MiPT
- Bevorzugter Name
- 5-MeO-MiPT
- IUPAC-Name
- N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
- CAS-Nummer der Stammverbindung (Referenz)
- 96096-55-8
- Summenformel
- C15H22N2O
- Molekulargewicht
- 246.35 g/mol
- InChIKey
- HEDOODBJFVUQMS-UHFFFAOYSA-N
- PubChem
- CID 2763156
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
5-Methoxy-N-methyl-N-isopropyltryptamine 5MeOMiPT 5-MeO MiPT
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
5-MeO-MiPT (Moxy)
Rezeptor-Telemetrie & Wirkmechanismus
5-MeO-MiPT combines a 5-methoxy indole with an N-methyl-N-isopropyl side chain. It is a 5-HT1A/5-HT2A agonist with a stimulating, tactile, and erotic bias and relatively modest open-eye visuals compared with 4-HO-MET or 4-HO-MiPT. Body load, nausea, and vasoconstriction are prominent.
Biotransformation & Active Metabolites
The parent compound is active orally, unlike 5-MeO-DMT. MAO still matters: an MAOI is not required for activity and makes the interaction dangerous. It is not 5-MeO-DMT (CAS 1019-45-0) and not 4-HO-MiPT (CAS 77872-43-6).
Zeitliche Pharmakokinetik
Stimulating, body-heavy, tactile psychedelic with entactogenic warmth, nausea, and fewer geometric visuals than the 4-hydroxy tryptamines.
- Onset 20–40 minutes
- Peak Window 2–3 hours
- Total Window 5–8 hours
- Residual / Half-Life After-effects 2–4 hours of residual stimulation and insomnia. Human plasma half-life is not established.
The oral heavy zone begins at 20 mg, only 5 mg above the top of the strong band (15–20 mg). Light and threshold both start at 3 mg. This is a low-milligram tryptamine, not a 4-HO-MET dose scaled by the similar name.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
3 mg
A light mood and body shift, increased tactile notice, still mostly functional.
Mild nausea or stomach tightness and a small pulse increase.
3–7 mg
Warm sociability, erotic tactile enhancement, stimulation, and soft sensory brightening.
Nausea, jaw tension, dilated pupils, and a stimulated rather than sedated body.
7–15 mg
Clear entactogenic and psychedelic effects, enhanced music and touch, some visuals, and a busy mind.
Pronounced nausea early on, vasoconstriction (cold hands), sweating, and a sustained faster heartbeat.
15–20 mg
Intense stimulation, anxiety or elevated dopaminergic tone, tactile overload, and a psychedelic state that is hard to treat as 'just body warmth'.
Strong nausea or vomiting, muscle tension, marked vasoconstriction, and restlessness.
20 mg+
Overwhelming confusion, panic, and a loss of the manageable erotic/stimulant character.
Severe nausea, headache, significant blood-pressure rise, and seizure risk with tramadol, lithium, or an MAOI.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Monoamine oxidase inhibition removes the main brake on serotonin while a 5-HT2A agonist is active, producing prolonged, unpredictable intensity, hypertensive reactions, and serotonin toxicity.
Lithium combined with serotonergic psychedelics is associated with seizures and poorly responsive medical emergencies even at otherwise ordinary amounts.
Additive seizure-threshold lowering and serotonergic load. Tramadol is repeatedly flagged on PsychonautWiki interaction lists for this class.
Hohes Risiko — Vermeiden
Stacks vasoconstriction and confusion. 5-MeO-DMT is a different, much sharper compound and is not a top-up for moxy.
Worsens nausea and judgment across a 5–8 hour course.
Vorsicht / Abschwächung
Often blunt psychedelic intensity while the physical load remains; they are not a reliable 'off switch' and do not make combinations with releasers safe.
Frequently deepens visuals, looping thoughts, and anxiety, including at amounts that felt moderate before cannabis.
Isomeren- & Strukturvergleich
5-MeO-MiPT is orally active and lasts 5–8 hours at 7–15 mg common, with more stimulation and less color than 4-HO-MiPT (common 15–25 mg). It is far less abrupt than vaporized 5-MeO-DMT (common 6–12 mg, 20–40 minutes) but shares the 5-methoxy warning about MAOIs. The N-isopropyl group is the same idea as in 4-HO-MiPT, not a reason to copy that dose.
Stabilität & Lagerung
Form: White, off-white, or tan crystalline powder or clumps as the freebase or a salt. · Salts dissolve in water; the freebase is more soluble in organic solvents and can be vaporized, which PsychonautWiki lists as a separate, not milder, route.
Airtight, cool, and dark. The oral active range begins at 3 mg, so a milligram scale plus a written label is part of storage safety.
Cross-Tolerance & Dependence Profile
Psychedelic tolerance builds quickly, halves in about 3 days, and is near baseline in about 7 days, with cross-tolerance to other 5-HT2A psychedelics. The stimulant edge can encourage repeated exposure; the 20 mg heavy line is close to the strong band, so repeated exposure is how overshoots happen.
Chemische Struktur und Molekülprofil
5-MeO-MiPT (N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine) ist eine Referenzverbindung aus der Stoffklasse Tryptamin-Derivate mit der Summenformel C15H22N2O und einer molaren Masse von 246.35 g/mol. Die Stammverbindung wird unter der CAS-Nummer 96096-55-8 sowie in der NCBI-PubChem-Datenbank unter CID 2763156 geführt (Standard-InChIKey: HEDOODBJFVUQMS-UHFFFAOYSA-N).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 5-MeO-MiPT zur chemischen Klasse Substituted tryptamines. Oxidationsempfindliches Tryptamin-Derivat; Referenzquellen vermerken strikte Kontraindikationen mit MAO-Hemmern (MAOI). Abhängigkeitspotenzial (PsychonautWiki): nicht gewohnheitsbildend. Dokumentierte Kreuztoleranz: psychedelic. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)